Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 11
153
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Cardiac oxidative stress and dysfunction by fine concentrated ambient particles (CAPs) are mediated by angiotensin-II

, , , &
Pages 963-972 | Received 28 Aug 2009, Accepted 18 Jun 2010, Published online: 18 Aug 2010

References

  • Antzelevitch C. 2001. Transmural dispersion of repolarization and the T wave. Cardiovasc Res 50:426–431.
  • Barker TA, Massett MP, Korshunov VA, Mohan AM, Kennedy AJ, Berk BC. 2006. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension 48:942–949.
  • Berl T. 2004. Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist. J Am Soc Nephrol 15 Suppl 1:S71–S76.
  • Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnason S, Stewart M, Guénette J, Potvin M, Kumarathasan P. 1998. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol 153:1873–1884.
  • Boveris A, Cadenas E, Reiter R, Filipkowski M, Nakase Y, Chance B. 1980. Organ chemiluminescence: noninvasive assay for oxidative radical reactions. Proceedings of the National Academy of Sciences of the United States of America 77:347–351.
  • Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. 2002. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105:1534–1536.
  • Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I; Expert Panel on Population,and Prevention Science of the American Heart Association. 2004. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109:2655–2671.
  • Brown NJ, Vaughan DE. 1998. Angiotensin-converting enzyme inhibitors. Circulation 97:1411–1420.
  • Cadenas E, Sies H. 1984. Low-level chemiluminescence as an indicator of singlet molecular oxygen in biological systems. Meth Enzymol 105:221–231.
  • Calderón-Garcidueñas L, Vincent R, Mora-Tiscareño A, Franco-Lira M, Henríquez-Roldán C, Barragán-Mejía G, Garrido-García L, Camacho-Reyes L, Valencia-Salazar G, Paredes R, Romero L, Osnaya H, Villarreal-Calderón R, Torres-Jardón R, Hazucha MJ, Reed W. 2007. Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution. Environ Health Perspect 115:1248–1253.
  • Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ. 1995. Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26:497–502.
  • Creason J, Neas L, Walsh D, Williams R, Sheldon L, Liao D, Shy C. 2001. Particulate matter and heart rate variability among elderly retirees: the Baltimore 1998 PM study. J Expo Anal Environ Epidemiol 11:116–122.
  • Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J. 1993. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br J Pharmacol 110:761–771.
  • D’Ippoliti D, Forastiere F, Ancona C, Agabiti N, Fusco D, Michelozzi P, Perucci CA. 2003. Air pollution and myocardial infarction in Rome: a case-crossover analysis. Epidemiology 14:528–535.
  • Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. 2003. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur Respir J Suppl 40:76s–80s.
  • Dockery DW, Luttmann-Gibson H, Rich DQ, Link MS, Mittleman MA, Gold DR, Koutrakis P, Schwartz JD, Verrier RL. 2005. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect 113:670–674.
  • Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. 2006. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 295:1127–1134.
  • Elder AC, Gelein R, Azadniv M, Frampton M, Finkelstein J, Oberdörster G. 2004. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol 16:461–471.
  • Elder AC, Gelein R, Finkelstein JN, Cox C, Oberdörster G. 2000. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal Toxicol 12 Suppl 4:227–246.
  • Esterbauer H, Cheeseman KH. 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407–421.
  • Ferreira R, Llesuy S, Milei J, Scordo D, Hourquebie H, Molteni L, de Palma C, Boveris A. 1988. Assessment of myocardial oxidative stress in patients after myocardial revascularization. Am Heart J 115:307–312.
  • Frampton MW, Utell MJ, Zareba W, Oberdörster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J. 2004. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst:1–47; discussion 49.
  • Garg S, Narula J, Marelli C, Cesario D. 2006. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias. Am J Cardiol 97:921–925.
  • Ghelfi E, Rhoden CR, Wellenius GA, Lawrence J, Gonzalez-Flecha B. 2008. Cardiac oxidative stress and electrophysiological changes in rats exposed to concentrated ambient particles are mediated by TRP-dependent pulmonary reflexes. Toxicol Sci 102:328–336.
  • Giannessi D, Del Ry S, Vitale RL. 2001. The role of endothelins and their receptors in heart failure. Pharmacol Res 43:111–126.
  • Godleski JJ. 2006. Responses of the heart to ambient particle inhalation. Clin Occup Environ Med 5:849–864.
  • Godleski JJ, Verrier RL, Koutrakis P, Catalano P, Coull B, Reinisch U, Lovett EG, Lawrence J, Murthy GG, Wolfson JM, Clarke RW, Nearing BD, Killingsworth C. 2000. Mechanisms of morbidity and mortality from exposure to ambient air particles. Res Rep Health Eff Inst :5–88; discussion 89.
  • Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R. 2000. Ambient pollution and heart rate variability. Circulation 101:1267–1273.
  • González-Flecha B, Llesuy S, Boveris A. 1991. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10:93–100.
  • Gurgueira SA, Lawrence J, Coull B, Murthy GG, González-Flecha B. 2002. Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation. Environ Health Perspect 110:749–755.
  • Halliwell B, Gutteridge JMC. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol 186:1–88.
  • Hanna IR, Taniyama Y, Szöcs K, Rocic P, Griendling KK. 2002. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899–914.
  • Henneberger A, Zareba W, Ibald-Mulli A, Rückerl R, Cyrys J, Couderc JP, Mykins B, Woelke G, Wichmann HE, Peters A. 2005. Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Perspect 113:440–446.
  • Holguín F, Téllez-Rojo MM, Hernández M, Cortez M, Chow JC, Watson JG, Mannino D, Romieu I. 2003. Air pollution and heart rate variability among the elderly in Mexico City. Epidemiology 14:521–527.
  • Hong YC, Lee JT, Kim H, Kwon HJ. 2002. Air pollution: a new risk factor in ischemic stroke mortality. Stroke 33:2165–2169.
  • Joy M, Lowe R. 1970. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature 228:1303–1304.
  • Kurdi M, De Mello WC, Booz GW. 2005. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37:1357–1367.
  • Ledingham JM, Laverty R. 2002. Fluvastatin remodels resistance arteries in genetically hypertensive rats, even in the absence of any effect on blood pressure. Clin Exp Pharmacol Physiol 29:931–934.
  • Li Z, Carter JD, Dailey LA, Huang YC. 2005. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspect 113:1009–1014.
  • Liao D, Creason J, Shy C, Williams R, Watts R, Zweidinger R. 1999. Daily variation of particulate air pollution and poor cardiac autonomic control in the elderly. Environ Health Perspect 107:521–525.
  • Llesuy S, Milei J, Picone V, González Flecha B, Beigelman R, Boveris A. 1995. Effect of vitamins A and E on ischemia-reperfusion damage in rabbit heart. Mol Cell Biochem 145:45–51.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
  • Martin SS, Boucard AA, Clément M, Escher E, Leduc R, Guillemette G. 2004. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. J Biol Chem 279:51415–51423.
  • Mehta PK, Griendling KK. 2007. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol, Cell Physiol 292:C82–C97.
  • Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T. 2002. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58–E65.
  • Peters A, Dockery DW, Muller JE, Mittleman MA. 2001. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 103:2810–2815.
  • Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, Baliff J, Oh JA, Allen G, Monahan K, Dockery DW. 2000. Air pollution and incidence of cardiac arrhythmia. Epidemiology 11:11–17.
  • Pladys P, Maison-Blanche P, Gout B, Badilini F, Bril A, Carré F. 2000. Influence of sympathetic heart rate modulation on RT interval rate adaptation in conscious dogs. Pacing Clin Electrophysiol 23:1604–1610.
  • Pope CA 3rd, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J, Villegas GM, Gold DR, Dockery DW. 1999. Heart rate variability associated with particulate air pollution. Am Heart J 138:890–899.
  • Rechtman M, Majewski H. 1993. A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig. Br J Pharmacol 110:289–296.
  • Rhoden CR, Lawrence J, Godleski JJ, González-Flecha B. 2004. N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci 79:296–303.
  • Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, González-Flecha B. 2005. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta 1725:305–313.
  • Rich DQ, Schwartz J, Mittleman MA, Link M, Luttmann-Gibson H, Catalano PJ, Speizer FE, Dockery DW. 2005. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol 161:1123–1132.
  • Riordan JF. 2003. Angiotensin-I-converting enzyme and its relatives. Genome Biol 4:225.
  • Rueckschloss U, Quinn MT, Holtz J, Morawietz H. 2002. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22:1845–1851.
  • Schwartz J, Morris R. 1995. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol 142:23–35.
  • Sioutas C, Koutrakis P, Godleski JJ, Ferguson ST, Kim CS, Burton R. 1997. Fine particle concentrators for inhalation exposures–Effect of particle size and composition. J Aerosol Sci 28:1057–1071.
  • Sioutas C, Koutrakis P, Burton RM. 1995. A technique to expose animals to concentrated fine ambient aerosols. Environ Health Perspect 103:172–177.
  • Tanaka M, Yamamoto S, Nakao K, Inukai T, Ogawa N, Katsumura H, Ohara N, Shukunobe K, Ono H. 1991. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models. Arzneimittelforschung 41:608–612.
  • Thomson E, Goegan P, Kumarathasan P, Vincent R. 2004. Air pollutants increase gene expression of the vasoconstrictor endothelin-1 in the lungs. Biochim Biophys Acta 1689:75–82.
  • Tsai SS, Goggins WB, Chiu HF, Yang CY. 2003. Evidence for an association between air pollution and daily stroke admissions in Kaohsiung, Taiwan. Stroke 34:2612–2616.
  • Viitasalo M, Oikarinen L, Swan H, Väänänen H, Glatter K, Laitinen PJ, Kontula K, Barron HV, Toivonen L, Scheinman MM. 2002. Ambulatory electrocardiographic evidence of transmural dispersion of repolarization in patients with long-QT syndrome type 1 and 2. Circulation 106:2473–2478.
  • Wellenius GA, Schwartz J, Mittleman MA. 2005. Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. Stroke 36:2549–2553.
  • Yue W, Schneider A, Stölzel M, Rückerl R, Cyrys J, Pan X, Zareba W, Koenig W, Wichmann HE, Peters A. 2007. Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. Mutat Res 621:50–60.
  • Zanobetti A, Schwartz J. 2005. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect 113:978–982.
  • Zhang H, Schmeisser A, Garlichs CD, Plötze K, Damme U, Mügge A, Daniel WG. 1999. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 44:215–222.
  • Zimmerman BG. 1981. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci 60:343–348.
  • Zisman LS, Asano K, Dutcher DL, Ferdensi A, Robertson AD, Jenkin M, Bush EW, Bohlmeyer T, Perryman MB, Bristow MR. 1998. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart. Circulation 98:1735–1741.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.